found tirzepatide A head-to-head study that patients on (Zepbound/Mounjaro) lost about 20% of their body weight, compared to 14% for those on semaglutide (Ozempic/Wegovy), though the study was funded Tirzepatide (Zepbound, Mounjaro): Weight Loss,
Description
Jeong C, Han N, Jeon N, Rhee S, jin, Staatz CE, Kim MS, et al
This is typically after the post-partum recovery period, once weight, BMI, metabolic health, and overall wellbeing have stabilised, which commonly takes around 68 weeks
Shima Hadidchi, MD, is committed to offering the latest advancements in weight management and chronic disease care
Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for treating type 2 diabetes and weight management in adults with obesity
Because the criterion for superiority was not met ( P =0.76), other outcomes were not statistically analyzed
